UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mast cells decrease efficacy of anti-angiogenic therapy by secreting matrix-degrading granzyme B

Nature communications, 2017-08, Vol.8 (1), p.269-11, Article 269

2017

Volltextzugriff (PDF)

The Pit-1/Pou1f1 transcription factor regulates and correlates with prolactin expression in human breast cell lines and tumors

Endocrine-related cancer, 2010-03, Vol.17 (1), p.73-85

2010

Volltextzugriff (PDF)

Correction: Role of growth arrest-specific gene 6-mer axis in multiple myeloma

Leukemia, 2020-09, Vol.34 (9), p.2542-2542

2020

Volltextzugriff (PDF)

696 Regulation of MMP-13 (collagenase-3) by the transcription factor Pit-1

European journal of cancer supplements, 2010, Vol.8 (5), p.175-175

2010

Volltextzugriff (PDF)

691 Function of the Pit-1 transcription factor in breast cancer

European journal of cancer supplements, 2010, Vol.8 (5), p.174-174

2010

Volltextzugriff (PDF)

The immunomodulatory activity of bemcentinib (BGB324): A first-in-class selective oral AXL inhibitor in patients with relapsed/refractory acute myeloid leukemia or myelodysplastic syndrome

Journal of clinical oncology, 2018-02, Vol.36 (5_suppl), p.70-70

2018

Volltextzugriff (PDF)

A first-in-patient phase I study of BGB324, a selective Axl kinase inhibitor in patients with refractory/relapsed AML and high-risk MDS

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.2561-2561

2016

Volltextzugriff (PDF)

PF259 THE COMBINATION OF BEMCENTINIB, A NOVEL, ORAL, SELECTIVE AXL‐INHIBITOR AND LOW‐DOSE CYTARABINE YIELDS DURABLE RESPONSES IN AML PATIENTS UNFIT FOR INTENSIVE CHEMOTHERAPY

HemaSphere, 2019-06, Vol.3 (S1), p.81-n/a

2019

Volltextzugriff (PDF)

Blockchain and Applications, 4th International Congress

1, 2023

Volltextzugriff (PDF)

Cetuximab Resistance in Head and Neck Cancer Is Mediated by EGFR-K521 Polymorphism

Cancer research (Chicago, Ill.), 2017-03, Vol.77 (5), p.1188-1199

2017

Volltextzugriff (PDF)

Influence of Androgens on Immunity to Self and Foreign: Effects on Immunity and Cancer

Frontiers in immunology, 2020-07, Vol.11, p.1184-1184

2020

Volltextzugriff (PDF)

The Role of TAM Receptors in Bone

International journal of molecular sciences, 2023-12, Vol.25 (1), p.233

2023

Volltextzugriff (PDF)

Functional Connectivity Bias in the Prefrontal Cortex of Psychopaths

Biological psychiatry (1969), 2015-11, Vol.78 (9), p.647-655

2015

Volltextzugriff (PDF)

BET-inhibition by JQ1 promotes proliferation and self-renewal capacity of hematopoietic stem cells

Haematologica (Roma), 2018-06, Vol.103 (6), p.939-948

2018

Volltextzugriff (PDF)

Regulation of bone homeostasis by MERTK and TYRO3

Nature communications, 2022-12, Vol.13 (1), p.7689-7689, Article 7689

2022

Volltextzugriff (PDF)

Bromodomain Protein BRD4 Is Required for Estrogen Receptor-Dependent Enhancer Activation and Gene Transcription

Cell reports (Cambridge), 2014-07, Vol.8 (2), p.460-469

2014

Volltextzugriff (PDF)

Functional connectivity alterations in brain networks relevant to self-awareness in chronic cannabis users

Journal of psychiatric research, 2014-04, Vol.51, p.68-78

2014

Volltextzugriff (PDF)

Prolonged inhibition of intratumoral mast cells enhances efficacy of low-dose antiangiogenic therapy

International journal of cancer, 2024-08

2024

Volltextzugriff (PDF)

1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum

Journal of neuroscience research, 2009-02, Vol.87 (3), p.723-732

2009

Volltextzugriff (PDF)

1,25‐Dihydroxyvitamin D 3 administration to 6‐hydroxydopamine‐lesioned rats increases glial cell line‐derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum

Journal of neuroscience research, 2009-02, Vol.87 (3), p.723-732

2009

Volltextzugriff (PDF)

Blockade of Myeloid-Derived Suppressor Cell Expansion with All- Trans Retinoic Acid Increases the Efficacy of Antiangiogenic Therapy

Cancer research (Chicago, Ill.), 2018-06, Vol.78 (12), p.3220-3232

2018

Volltextzugriff (PDF)

Sexual dimorphism in solid and hematological malignancies

Seminars in immunopathology, 2019-03, Vol.41 (2), p.251-263

2019

Volltextzugriff (PDF)

Breakdown in the brain network subserving moral judgment in criminal psychopathy

Social cognitive and affective neuroscience, 2012-11, Vol.7 (8), p.917-923

2012

Volltextzugriff (PDF)

1 – 25 von 68

Suche als RSS-Feed

Aktive Filter

ThemaSignal Transduction

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(65)
Mit Volltextzugriff
(65)

Publikationsform

Sprache

Englisch
(68)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Mast cells decrease efficacy of anti-angiogenic therapy by secreting matrix-degrading granzyme B

P548: BEMCENTINIB COMBINED WITH LOW‐DOSE CYTARABINE IS EFFICACIOUS AND WELL TOLERATED IN RELAPSED AML PATIENTS UNFIT FOR INTENSIVE CHEMOTHERAPY. UPDATES FROM THE ONGOING PHASE II TRIAL (NCT02488408)

The Pit-1/Pou1f1 transcription factor regulates and correlates with prolactin expression in human breast cell lines and tumors

Correction: Role of growth arrest-specific gene 6-mer axis in multiple myeloma

696 Regulation of MMP-13 (collagenase-3) by the transcription factor Pit-1

691 Function of the Pit-1 transcription factor in breast cancer

The immunomodulatory activity of bemcentinib (BGB324): A first-in-class selective oral AXL inhibitor in patients with relapsed/refractory acute myeloid leukemia or myelodysplastic syndrome

A first-in-patient phase I study of BGB324, a selective Axl kinase inhibitor in patients with refractory/relapsed AML and high-risk MDS

PF259 THE COMBINATION OF BEMCENTINIB, A NOVEL, ORAL, SELECTIVE AXL‐INHIBITOR AND LOW‐DOSE CYTARABINE YIELDS DURABLE RESPONSES IN AML PATIENTS UNFIT FOR INTENSIVE CHEMOTHERAPY

Blockchain and Applications, 4th International Congress

Cetuximab Resistance in Head and Neck Cancer Is Mediated by EGFR-K521 Polymorphism

Influence of Androgens on Immunity to Self and Foreign: Effects on Immunity and Cancer

The Role of TAM Receptors in Bone

Functional Connectivity Bias in the Prefrontal Cortex of Psychopaths

BET-inhibition by JQ1 promotes proliferation and self-renewal capacity of hematopoietic stem cells

Evaluation of soluble carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: A biomarker analysis from the geparquinto phase III neoadjuvant breast cancer trial

Regulation of bone homeostasis by MERTK and TYRO3

Bromodomain Protein BRD4 Is Required for Estrogen Receptor-Dependent Enhancer Activation and Gene Transcription

Functional connectivity alterations in brain networks relevant to self-awareness in chronic cannabis users

Prolonged inhibition of intratumoral mast cells enhances efficacy of low-dose antiangiogenic therapy

1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum

1,25‐Dihydroxyvitamin D 3 administration to 6‐hydroxydopamine‐lesioned rats increases glial cell line‐derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum

Blockade of Myeloid-Derived Suppressor Cell Expansion with All- Trans Retinoic Acid Increases the Efficacy of Antiangiogenic Therapy

Sexual dimorphism in solid and hematological malignancies

Breakdown in the brain network subserving moral judgment in criminal psychopathy

Aktive Filter

Suchergebnisse filtern